Corinne Epperly
Direttore/Membro del Consiglio presso IN8BIO, INC.
Patrimonio netto: 85 246 $ in data 30/04/2024
Profilo
Corinne D.
Epperly is a professional with experience in various firms.
She has worked as a Director at IN8bio, Inc. since 2023.
Previously, she worked as an Independent Director at AVEO Pharmaceuticals, Inc. from 2021 to 2023, a Research Analyst at Goldman Sachs International in 2010, the Chief Operating Officer at Vascular Biogenics Ltd.
from 2017 to 2018, the Senior Vice President-Strategy & Operations at Iovance Biotherapeutics, Inc. from 2019 to 2020, and the Chief Operating Officer at Cargo Therapeutics, Inc. from 2021 to 2023.
Dr. Epperly received her undergraduate degree from the University of Virginia and her graduate and doctorate degrees from The University of North Carolina at Charlotte.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
IN8BIO, INC.
0.19% | 17/04/2024 | 81 967 ( 0.19% ) | 85 246 $ | 30/04/2024 |
Posizioni attive di Corinne Epperly
Società | Posizione | Inizio |
---|---|---|
IN8BIO, INC. | Direttore/Membro del Consiglio | 07/12/2023 |
Precedenti posizioni note di Corinne Epperly
Società | Posizione | Fine |
---|---|---|
CARGO THERAPEUTICS, INC. | Direttore operativo | 01/12/2023 |
AVEO PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 19/01/2023 |
IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
NOTABLE LABS, LTD. | Direttore operativo | 01/01/2018 |
Goldman Sachs International
Goldman Sachs International Financial ConglomeratesFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Analyst-Equity | 01/10/2010 |
Formazione di Corinne Epperly
The University of North Carolina at Charlotte | Doctorate Degree |
University of Virginia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
CARGO THERAPEUTICS, INC. | Health Technology |
IN8BIO, INC. | Health Technology |
Aziende private | 3 |
---|---|
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Goldman Sachs International
Goldman Sachs International Financial ConglomeratesFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Finance |
- Borsa valori
- Insiders
- Corinne Epperly